IperionX Limited Sponsored ADR (NASDAQ:IPX) Stock Has Consensus Price Target of $42.00

Shares of IperionX Limited Sponsored ADR (NASDAQ:IPX) have been given an average recommendation of “Moderate Buy” by the seven research firms that are presently covering the stock, MarketBeat reports. One research analyst has rated the stock with a sell rating and six have given a buy rating to the company. The average 1-year price objective among brokerages that have covered the stock in the last year is $42.00.

A number of equities analysts recently commented on the company. Jefferies Financial Group initiated coverage on IperionX in a report on Wednesday, September 2nd. They issued a “buy” rating and a $26.00 price objective on the stock. Roth Capital set a $53.00 target price on shares of IperionX in a research report on Wednesday, August 5th. Weiss Ratings reiterated a “sell (e+)” rating on shares of IperionX in a research note on Thursday, October 15th. Finally, B. Riley Financial cut their price objective on IperionX from $52.00 to $34.00 and set a “buy” rating on the stock in a research note on Wednesday, September 30th.

Institutional Investors Weigh In On IperionX

A number of hedge funds have recently bought and sold shares of the company. Private Advisor Group LLC acquired a new stake in IperionX in the 3rd quarter valued at approximately $840,000. DLD Asset Management LP bought a new stake in IperionX in the 1st quarter valued at $260,000. Connective Capital Management LLC bought a new position in shares of IperionX during the 2nd quarter worth about $160,000. Finally, GAMMA Investing LLC raised its position in shares of IperionX by 40.3% during the second quarter. GAMMA Investing LLC now owns 1,681 shares of the company’s stock valued at $50,000 after buying an additional 483 shares during the last quarter. 2.76% of the stock is currently owned by institutional investors.

IperionX Price Performance

Shares of IPX opened at $15.91 on Friday. IperionX has a 52 week low of $12.14 and a 52 week high of $61.45. The company has a quick ratio of 2.95, a current ratio of 3.24 and a debt-to-equity ratio of 0.04. The company’s 50 day moving average price is $16.98 and its 200 day moving average price is $29.05.

IperionX (NASDAQ:IPX) last posted its quarterly earnings results on Thursday, July 30th. The company reported ($0.50) earnings per share for the quarter. As a group, sell-side analysts forecast that IperionX will post -0.34 earnings per share for the current fiscal year.

About IperionX

IperionX Limited is a materials technology company focused on developing a U.S.-centered supply chain for titanium and other critical minerals. The company develops technologies to produce titanium metal and alloys from mineral feedstocks and recycled materials, with the goal of offering an alternative to conventional titanium production methods. IperionX’s proprietary processes include Hydrogen Assisted Magnesiothermic Reduction (HAMR) and Hydrogen Sintering and Phase Transformation (HSPT). Its planned products include titanium powders and other materials for applications such as additive manufacturing, aerospace, defense, automotive and consumer products.